SCHEMBL3517401

SCHEMBL3517401

CCOC(=O)c1c(O)c2cc(C(=O)N3CCC(CCc4ccccc4)CC3)cnc2n(O)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
P2RY12 Q9H244 2/20 0.41
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
KDM4E B2RXH2 2/20 0.39
SPR P35270 1/20 0.38
RECQL P46063 1/20 0.38
USP2 O75604 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3514695 0.95 OPRK1 (0.42) ALDH1A1GAASMN1; SMN2HSD17B10MEN1
SCHEMBL14313861 0.89 MEN1 (0.46) MEN1KMT2AGRIN2DGRIN3BGRIN1
SCHEMBL3517631 0.89 MEN1 (0.45) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL3515732 0.85 GRM5 (0.39) MEN1KMT2AP2RY12KDM4ERECQL
SCHEMBL14313880 0.84 MEN1 (0.44) MEN1KMT2AGRIN2DGRIN3BGRIN1
SCHEMBL3517790 0.80 MAPT (0.48) ALDH1A1SMN1; SMN2HSD17B10MEN1KMT2A
SCHEMBL3517896 0.78 KDM4E (0.42) ALDH1A1GAASMN1; SMN2P2RY12KDM4E
SCHEMBL14313887 0.77 MEN1 (0.50) MEN1KMT2AGRIN2DGRIN3BGRIN1
SCHEMBL3518509 0.77 KDM4E (0.50) ALDH1A1GAASMN1; SMN2KDM4ERECQL
SCHEMBL3517034 0.77 KDM4E (0.47) ALDH1A1SMN1; SMN2HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL ALDH1A1 1486/4885GAA 161/4885SMN1; SMN2 1566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.